Earnings per Share |
Common stock equivalents of 151,112 for the year ended December 31, 2015, and 132,162 and 365,177 for the years ended December 31, 2014 and 2013, respectively, were excluded from the calculation of diluted net income per common share as the effect would have been anti-dilutive.
|
|
For the Years Ended December 31,
|
|
|
|
2015
|
|
|
2014
|
|
|
2013
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
509,724
|
|
|
$
|
493,241
|
|
|
$
|
377,215
|
|
Allocation of undistributed income to Series B Preferred Stock
|
|
|
—
|
|
|
|
—
|
|
|
|
(3,825
|
)
|
Net income available to common stockholders for basic net
income per common share
|
|
$
|
509,724
|
|
|
$
|
493,241
|
|
|
$
|
373,390
|
|
Add back:
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of undistributed income to Series B Preferred Stock
|
|
|
—
|
|
|
|
—
|
|
|
|
3,825
|
|
Net income available to common stockholders for diluted net
income per common share
|
|
$
|
509,724
|
|
|
$
|
493,241
|
|
|
$
|
377,215
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding for basic net
income per common share (a)
|
|
|
5,375,707
|
|
|
|
5,788,944
|
|
|
|
6,227,646
|
|
Weighted average impact of assumed Series B Preferred
Stock conversion
|
|
|
—
|
|
|
|
—
|
|
|
|
63,789
|
|
Weighted average impact of dilutive equity instruments
|
|
|
59,459
|
|
|
|
73,076
|
|
|
|
93,356
|
|
Weighted average shares for diluted net income per common
share
|
|
|
5,435,166
|
|
|
|
5,862,020
|
|
|
|
6,384,791
|
|
Net income per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.09
|
|
|
$
|
0.09
|
|
|
$
|
0.06
|
|
Diluted
|
|
$
|
0.09
|
|
|
$
|
0.08
|
|
|
$
|
0.06
|
|
(a)
|
The 7% Exchangeable Senior Subordinated Notes due 2014 (the “Exchangeable Notes”) were fully converted into shares of our common stock as of December 1, 2014. During the year ended December 31, 2013, the common stock reserved for conversion in connection with the Exchangeable Notes were considered to be anti-dilutive in our calculation of diluted net income per share.
|
|